Indian opening batsman Prithvi Shaw has been suspended for 8 months by the BCCI for an inadvertent doping violation.

A BCCI press release read, "Mr. Shaw had provided a urine sample as part of the BCCI's anti-doping testing program during the Syed Mushtaq Ali Trophy match on 22nd February 2019 in Indore. His sample was subsequently tested and found to contain Terbutaline. Terbutaline, a specified substance, is prohibited both In & Out of Competition in the WADA Prohibited List of Substances."

The Test cricketer stated that he had consumed the drug to treat a respiratory tract infection. The board found his explanation satisfactory and ruled out the possibility of Shaw using it as a performance-enhancing drug. Hence, the BCCI have back-tracked the date of consumption of the drug and suspended him till November 15.

"I accept my fate with all sincerity. I have to take this in my stride and hope it inspires others in our sports fraternity too in India. We as athletes need to be extremely careful in taking any medicine for the smallest of medical ailments even if the medicine is available over the counter," Prithvi Shaw later responded on Twitter.
 

pic.twitter.com/KXYHcUcBR0

— Prithvi Shaw (@PrithviShaw) July 30, 2019